Skip to content
10-Q

Quarterly Report

SYNEOS HEALTH, INC.

0000950170-23-020079

← back to feed
Filed
May 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 2, 2023 103.65M sh
Shares Diluted Q1 2023 · Mar 31, 2023 103.33M sh
Shares Diluted Q1 2023 · Mar 31, 2022 104.41M sh
Stock Repurchased Q1 2023 · Mar 31, 2023 $0
Stock Repurchased Q1 2023 · Mar 31, 2022 $149.96M
Capex Q1 2023 · Mar 31, 2023 $27.51M
Capex Q1 2023 · Mar 31, 2022 $23.47M
Operating Cash Flow Q1 2023 · Mar 31, 2023 $30.42M
Operating Cash Flow Q1 2023 · Mar 31, 2022 $70.89M
Long Term Debt Q1 2023 · Mar 31, 2023 $2.61B
Long Term Debt Q1 2023 · Dec 31, 2022 $2.61B
Stockholders Equity Q1 2023 · Mar 31, 2023 $3.45B
Stockholders Equity Q1 2023 · Dec 31, 2022 $3.5B
Stockholders Equity Q1 2023 · Mar 31, 2022 $3.3B
Stockholders Equity Q1 2023 · Dec 31, 2021 $3.41B
Current Liabilities Q1 2023 · Mar 31, 2023 $1.69B
Current Liabilities Q1 2023 · Dec 31, 2022 $1.72B
Total Liabilities Q1 2023 · Mar 31, 2023 $4.64B
Total Liabilities Q1 2023 · Dec 31, 2022 $4.7B
Current Assets Q1 2023 · Mar 31, 2023 $1.95B
Current Assets Q1 2023 · Dec 31, 2022 $1.94B
Total Assets Q1 2023 · Mar 31, 2023 $8.1B
Total Assets Q1 2023 · Dec 31, 2022 $8.2B
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.70
Eps Diluted Q1 2023 · Mar 31, 2022 $0.44
Eps Basic Q1 2023 · Mar 31, 2023 −$0.70
Eps Basic Q1 2023 · Mar 31, 2022 $0.45
Sga Expense Q1 2023 · Mar 31, 2023 $161.52M
Sga Expense Q1 2023 · Mar 31, 2022 $140.17M
Net Income Q1 2023 · Mar 31, 2023 −$72.15M
Net Income Q1 2023 · Mar 31, 2022 $46.18M
Operating Income Q1 2023 · Mar 31, 2023 −$39.54M
Operating Income Q1 2023 · Mar 31, 2022 $73.9M
Revenue Q1 2023 · Mar 31, 2023 $1.36B
Revenue Q1 2023 · Mar 31, 2022 $1.34B